400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / MAPK/ERK Pathway / MEK / Cobimetinib hemifumarate/考比替尼半富马酸盐
CAS No.: 1369665-02-0
Synonyms: GDC-0973 hemifumarate;XL-518 hemifumarate;XL-518
Cobimetinib, also known as GDC-0973 and XL-518, RG 7420, is an orally bioavailable small-molecule inhibitor of mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity. MEK inhibitor GDC-0973 specifically binds to and inhibits the catalytic activity of MEK1, resulting in inhibition of extracellular signal-related kinase 2 (ERK2) phosphorylation and activation and decreased tumor cell proliferation. Preclinical studies have demonstrated that this agent is effective in inhibiting the growth of tumor cells bearing a B-RAF mutation, which has been found to be associated with many tumor types.
生物活性
实验方案
技术信息
CAS号 | 1369665-02-0 | 储存条件 |
|
|
分子式 | C25H25F3IN3O6 | 运输 | 蓝冰 | |
分子量 | 647.38 | 别名 | GDC-0973 hemifumarate;XL-518 hemifumarate;XL-518;GDC-0973;RG-7420;cobimetinib;Cotellic;考比替尼半富马酸盐 |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网